Amy Green, NP
Gerontology · Sherman, TXNPI 1518510833
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $869 and has fallen 96.1% since, to $34 in 2025.
Across 90 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$200
- United Therapeutics Corporation$191
- AstraZeneca$183
- Mylan Specialty L.p.$164
- Actelion Pharmaceuticals US, Inc.$117
- Insmed, Inc.$113
- plus $632 from 14 others
What the payments were for
- Food & beverage$1,600100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 9 | $200 |
| United Therapeutics Corporation | 10 | $191 |
| AstraZeneca | 11 | $183 |
| Mylan Specialty L.p. | 11 | $164 |
| Actelion Pharmaceuticals US, Inc. | 5 | $117 |
| Insmed, Inc. | 7 | $113 |
| GSK | 6 | $100 |
| Boehringer Ingelheim | 7 | $99 |
| Baxter Healthcare | 5 | $89 |
| Grifols USA, LLC | 4 | $79 |
| Jazz Pharmaceuticals Inc. | 3 | $50 |
| Advanced Respiratory, Inc | 2 | $34 |
| Avanos Medical | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Gilead | 2 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Itamar Medical Inc | 1 | $12 |
How this compares
$1,600 in reported general payments places this provider in the 75th percentile of 653 gerontology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gerontology in Sherman
- Kimberly WelchCoppell$113K
- Tiffany KesslerDallas$84K
- Jennifer WestFort Worth$67K
- Bailey EstesAbilene$34K
- Scott ZelaHouston$28K
- Marissa Marti-SmithDallas$27K
- Andrew BargerAustin$22K
- Meagan ChavarriaHouston$21K
- Samantha BoggsGalveston$15K
- Amber ArmstrongAustin$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.